The prognosis of patients with CD54-negative tumours is significantly poorer than those with CD54-positive tumours, suggesting that low CD54 expression is closely associated with metastasis and may be a useful indicator of prognosis [118]. The gene discussed is ICAM1; the disease is neoplasm.